Publications...
 

 

  1. E. Kovacs, W. Weber and HJ. Müller
    Age-related variations in the DNA-repair synthesis after UV-C irradiation in unstimulated lymphocytes of healthy blood donors. Mutation Research 131, 231-237 (1984).
     
  2. HJ. Müller, N. Bürki, A. Gencik, A. Gencikova, E. Kovacs, M. Roth, N. Trächslin, B. Voegtli, W. Weber
    Familiäre Tumorkrankheiten. Erste Ergebnisse einer Erhebung über ihr Vorkommen in Basel. Sozial- und Präventivmedizin 30, 28-32 (1985).
     

  3. ​E. Kovacs, D. Stucki, W. Weber and HJ. Müller
    Impaired DNA-repair synthesis in lymphocytes of breast cancer patients. Eur J Cancer Clin Oncol 22, 863-869 (1986).
     

  4. E. Kovacs and A. Almendral

    Reduced DNA repair synthesis in healthy women having first degree relatives with breast cancer. Eur J Cancer Clin Oncol 23, 1051-1057 (1987).
     

  5. E. Kovacs, C. Nissen, B. Speck and E. Signer

    Repair of UV-induced DNA damage in aplastic anaemia: Changes after treatment with antilymphocyte globulin (ALG). Eur J Haematol 40,430-436 (1988).
     

  6. E. Kovacs and H. Langemann

    Defective DNA repair in a large family having a high occurrence of cancer. Oncology 45, 444-447 (1988).
     

  7. E. Kovacs and H. Langemann

    Investigation of the repair of single-strand breaks in human DNA using alkaline gel electrophoresis.
    Radiation Research 124, 137-140 (1990).
     

  8. E. Kovacs and H. Langemann

    Differences in the kinetics of DNA repair in cancer patients and healthy controls. Oncology 48, 312-316 (1991).
     

  9. E. Kovacs, T. Hajto and K. Hostanska

    Improvement of DNA repair in lymphocytes of breast cancer patients treated with Viscum album extract (Iscador). Eur J Cancer 27, 1672-1676 (1991). 
     

  10. Eva Kovacs, H. langemann and H. Ludwig

    Do chemo-and radiotherapy affect the DNA repair ability of lymphocytes? Arch Gynecol Obstet 251, 121-126 (1992).
     

  11. E. Kovacs, M. Meichsner-Frauli and H. Ludwig

    lnterleukin-2 receptor positive cells in human decidua during the first trimester of pregnancy and their association with macrophages. Arch Gynecol Obstet 251, 93-100 (1992).
     

  12. E. Kovacs

    Serum levels of IL-12 and the production of IFN-gamma, IL-2 and IL-4 by peripheral blood mononuclear (PBMC) in cancer patients treated with Viscum album extract. Biomedicine & Pharmacotherapy 54, 305-310 (2000).
     

  13. E. Kovacs

    The serum levels of IL-12 and IL-16 in cancer patients. Relation to the tumour stage and previous therapy. Biomedicine & Pharmacotherapy 55, 111-116 (2001).
     

  14. E. Kovacs

    Investigation of interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6R) and soluble gp130 (sgp130) in sera of cancer patients. Biomedicine & Pharmacotherapy 55, 391-396 (2001).
     

  15. E. Kovacs

    Zur Rolle der DNA-Reparatur In der Karzinogenese und der Effekt von Iscador auf die DNA-Reparaturfähigkeit bei Krebspatienten. Mistelteinn 2, 34-43 (2001).
     

  16. JJ. Kuehn and E. Kovacs

    Lectin compared to mistletoe use: experimental therapy form with preclinical verified risk potential. Deutsche Medizinische Wochenschrift 127, 2637-2638 (2002).
     

  17. E. Kovacs

    The in vitro effect of Viscum album extract on DNA repair of peripheral blood mononuclear cells (PBMC) in cancer patients. Phytotherapy Research 16, 143-147 (2002).
     

  18. E. Kovacs and JJ Kuehn

    Measurements of IL-6, soluble IL-6 receptor and soluble gp130 in sera of B-cell lymphoma patients. Does Viscum album treatment affect these parameters? Biomedicine & Pharmacotherapy 56, 152-158 (2002).
     

  19. E. Kovacs

    How does interleukin-6 affect the membrane expressions of interleukin-6 receptor and gp130 and the proliferation of the human myeloma cell line OPM-2? Biomedicine & Pharmacotherapy 57, 489-494 (2003).
     

  20. E. Kovacs

    Effects of Viscum album (VA) therapy in cancer patients. Relation with interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6R) and soluble gp130 (sgp130). The Journal of Alternative and Complementary Medicine 10, 241-246 (2004). 
     

  21. E. Kovacs

    The serum levels of soluble intercellular adhesion molecule-1 (sICAM-1) and soluble gp130 (sgp130) in different tumour stages. Correlation between the two parameters in progression of malignancy.
    Biomedicine & Pharmacotherapy 59, 498-500 (2005).
     

  22. E. Kovacs, S. Link and U. Toffol-Schmidt

    Cytostatic and cytocidal effects of mistletoe (Viscum album L.) Quercus extract Iscador.
    Drug Research 56, 467-473 (2006).
     

  23. E. Kovacs

    Multiple myeloma and B cell lymphoma. Investigation of IL-6, IL-6 receptor antagonist (IL-6RA) and gp130 antagonist (gp130A) using various parameters in an in vitro model.
    The Scientific World Journal 6, 888-898 (2006).
     

  24. E. Kovacs, S. Link, U. Toffol-Schmidt

    Comparison of Viscum album QuFrF extract with Vincristine in an in vitro model of human B cell lymphoma WSU-1.
    Drug Research 58, 592-597 (2008).
     

  25. E. Kovacs

    Investigation of the proliferation, apoptosis/necrosis and cell cycle phases in several human multiple myeloma cell lines. Comparison of Viscum album QuFrF extract with Vincristine in an in vitro model.
    The Scientific World Journal 10, 311-320 (2010).
     

  26. E. Kovacs

    Interleukin-6 leads to Interleukin-10 production in several human multiple myeloma cell lines. Does Interleukin-10 enhance the proliferation of these cells?
    Leukemia Research 34, 912-916 (2010).
     

  27. E. Kovacs-Benke

    Tumor necrosis factor-alpha (TNF-alpha) production in human multiple myeloma cells is influenced only by Interleukin-6. (Manuscript in preparation).
     

  28. E. Kovacs-Benke

    Investigation of the Proliferation, Apoptosis/Necrosis, and Cell Cycle Phases in Several Human Multiple Myeloma Cell Lines. Comparison of Viscum album QuFrF Extract with Vincristine in an In Vitro Model.The Scientific World Journal 10, 311-20 (2010).
     

  29. E. Kovacs-Benke

    The effect of minerals in natural mineral water on the serum-parameters of bone-metabolism. Research Gate, (2014).
     

  30. E. Kovacs-Benke

    Additive/Synergistic Effects of Interleukin-6 and Interleukin-10 on the Proliferation of Human Myeloma Cells. International Journal of Hematology Research 1(3), 74-78 (2015).
     

  31. E. Kovacs-Benke

    Low/High Proliferation Rate of Human Myeloma Cells, Investigation of Interleukin-6 and Interleukin-6 Receptor Antagonist. International Journal of Hematology Research
    2(1), 115-119 (2016).
     

  32. E. Kovacs-Benke

    Monitoring Disease Status in Multiple Myeloma in View of Proliferation-leading Cytokines. Journal of Hematology & Multiple Myeloma, Volume 2 / Issue 1 / Article 1010 (2017).
     

  33. E. Kovacs-Benke

    Case Report: A 12-Year History of Autoimmune Disease Systemic Lupus Erythematosus, American Journal of Medical Case Reports, 2016, Vol. 4, No. 5, 175-179